Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
CC transcript
Appointed director
Quarterly results

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 1,550 shares @ $26.33, valued at $40.8k
07/06/2023 4 Oliver Tracie (Chief Commercial Officer) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 8,925 shares @ $35.31, valued at $315.1k
07/05/2023 4 Hamilton James C (Chief Discovery/Trans Medicine) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 3,000 shares @ $35.53, valued at $106.6k
06/29/2023 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $36.2, valued at $543k
05/08/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 6,500 shares @ $40.9, valued at $265.9k
05/05/2023 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 54,928 shares @ $39.14, valued at $2.1M
Sold 24,008 shares @ $38.97, valued at $935.6k
Sold 25,992 shares @ $40.02, valued at $1M
Exercised 54,928 options to buy @ $2.01, valued at $110.4k
Exercised 50,000 options to buy @ $2.01, valued at $100.5k
03/06/2023 4 OLUKOTUN ADEOYE Y (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 11,350 shares @ $32.65, valued at $370.6k
03/01/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 875 shares @ $32.62, valued at $28.5k
01/12/2023 4 Ferrari Mauro (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 De Backer Marianne (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Disposed/sold 1,764 shares @ $0
Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 PERRY MICHAEL S (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 3,200 shares @ $30, valued at $96k
Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 OLUKOTUN ADEOYE Y (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 4,593 options to buy @ $33.03, valued at $151.7k
Granted 7,867 shares @ $0
01/06/2023 4 O'Brien Patrick (COO and General Counsel) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 7,500 shares @ $37.39, valued at $280.4k
01/06/2023 4 Hamilton James C (Chief Discovery/Trans Medicine) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 7,230 shares @ $37.4, valued at $270.4k
Sold 6,573 shares @ $37.4, valued at $245.8k
01/05/2023 4 Oliver Tracie (Chief Commercial Officer) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 500 shares @ $0
01/05/2023 4 San Martin Javier (Chief Medical Officer) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 60,000 shares @ $0
01/05/2023 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 60,000 shares @ $0
01/05/2023 4 O'Brien Patrick (COO and General Counsel) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 2,653 shares @ $37.53, valued at $99.6k
Sold 5,527 shares @ $38.54, valued at $213k
Sold 500 shares @ $39.74, valued at $19.9k
Sold 70 shares @ $40.8, valued at $2.9k
Sold 2,894 shares @ $37.58, valued at $108.8k
Sold 5,286 shares @ $38.58, valued at $203.9k
Sold 300 shares @ $39.55, valued at $11.9k
Sold 270 shares @ $40.53, valued at $10.9k
Granted 65,000 shares @ $0
01/05/2023 4 Hamilton James C (Chief Discovery/Trans Medicine) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 1,194 shares @ $37.46, valued at $44.7k
Sold 2,837 shares @ $38.53, valued at $109.3k
Sold 300 shares @ $39.74, valued at $11.9k
Sold 136 shares @ $40.54, valued at $5.5k
Sold 1,642 shares @ $37.49, valued at $61.6k
Sold 3,682 shares @ $38.52, valued at $141.8k
Sold 300 shares @ $39.56, valued at $11.9k
Sold 247 shares @ $40.52, valued at $10k
Granted 60,000 shares @ $0
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2022 4 O'Brien Patrick (General Counsel) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 32,000 options to buy @ $6.15, valued at $196.8k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Disposed/sold 551,197 shares @ $0
07/11/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 2,501 options to buy @ $14.54, valued at $36.4k
06/29/2022 3 Oliver Tracie (Chief Commercial Officer) has filed a Form 3 on ARROWHEAD PHARMACEUTICALS, INC.
05/05/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/14/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 40,853 shares @ $53.11, valued at $2.2M
Sold 42,153 shares @ $52.28, valued at $2.2M
Sold 61,482 shares @ $50.9, valued at $3.1M
Sold 1,900 shares @ $50.51, valued at $96k
Exercised 146,388 options to buy @ $5.19, valued at $759.8k
01/07/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 11,806 options to buy @ $5.19, valued at $61.3k
01/07/2022 4 O'Brien Patrick (General Counsel) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 12,434 shares @ $60.49, valued at $752.1k
Sold 10,350 shares @ $61.88, valued at $640.5k
Sold 5,000 shares @ $62.49, valued at $312.5k
Sold 4,400 shares @ $63.75, valued at $280.5k
Sold 316 shares @ $64.35, valued at $20.3k
Gifted 800 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy